Five Participants Enrolled in Phase 2 Study at the Bronx, New York Veterans Affairs Medical Center

As of August 8, 2022, a total of five participants have been enrolled and the Bronx VA site continues to actively screen for new participants. 

Enrollment is continuing for this Phase 2, open-label study on the effectiveness of MDMA-assisted therapy in U.S. Veterans with chronic PTSD. This study is a comparative study that assesses two versus three active MDMA-assisted sessions.